ARBORETUM VENTURES NEWS
Arboretum Ventures II Final Close of $73 million
In February, Arboretum Ventures announced the final closing of its second investment fund, with commitments totaling $73 million. The latest fund follows Arboretum's $24 million debut fund, which closed in 2005. The firm remains focused on investing in promising healthcare and life science companies across the U.S. As with the first fund, Arboretum Ventures II is operated by Managing Directors Jan Garfinkle and Tim Petersen, with the support of five additional investment and professional staff. Arboretum's investment team benefits from the input of its advisory group, which includes past and current CEOs of successful healthcare companies such as Medtronic and Guidant Corporation. New investors include foundations, pension funds and fund of funds, in addition to many returning institutional and high net worth individual investors.

Successful companies from the first fund include HealthMedia (acquired by Johnson & Johnson) and Asterand (traded on the London Stock Exchange), as well as a number of privately held companies. Arboretum has now made investments in 18 companies across its two funds.
Arboretum Portfolio News
Arboretum Invests in Two New Companies

Aptus Endosystems (Sunnyvale, CA) is a medical device company developing advanced technology for the endovascular treatment of aortic aneurysms. In January, Arboretum joined the $33 million Series C round which provides capital for the company to apply for FDA approval of its first device.

CerviLenz, Inc. (Cleveland, OH) is a manufacturer and distributor of a disposable device used to predict the risk of preterm birth in pregnant women. In April, Arboretum Ventures led the $4 million initial round of venture funding and was joined by Chrysalis Ventures (Louisville, KY).

Recent Portfolio Company Highlights

Asterand plc (Detroit, MI) was selected as the best performing stock on the London Stock Exchange for 2008 by the Financial Times.

Advanced ICU Care, Inc. (St. Louis, MO) Modern Healthcare named Advanced ICU Care Chief Executive Officer Dr. Mary Jo Gorman to its list of the "Top 25 Women in Healthcare."

HandyLab, Inc. (Ann Arbor, MI) signed several major partnership and license agreements with Becton Dickinson, Qiagen, and Nanogen.
Arboretum Adds Strategic Limited Partner to Team
Arboretum Ventures is pleased to announce the addition of Tom Kinnear, Ph.D., as a strategic limited partner. Tom will participate with Arboretum's investment team in evaluating new investment opportunities and will provide strategic advice to the firm's Managing Directors. Tom is the Eugene Applebaum Professor of Entrepreneurial Studies and Professor of Marketing at the University of Michigan Ross School Of Business. He is also the Executive Director of the Samuel Zell and Robert H. Lurie Institute for Entrepreneurial Studies. In addition to a long history of successfully funding and mentoring entrepreneurial companies, including BlueGill Technologies and Accuri Cytometers, Tom is also a highly regarded researcher in the marketing field. He is currently the Board Chair of the American Marketing Association. He holds undergraduate and LLD (honoris causa) degrees from Queen's University at Kingston, Ontario, an MBA from Harvard University, and a Ph.D. in Business Administration from the University of Michigan.

SPRING 2009

  • Arboretum Ventures II Final Close of $73 million

  • Arboretum Portfolio News

  • Arboretum Adds Strategic Limited Partner to Team


    		•

    Quick Links

  • Arboretum Ventures

    •

        SIGN-UP
    Sign up for
    our Newsletter


    Click on a company name below to be directed to their website: